U.S. Markets closed

CASI Pharmaceuticals, Inc. (CASI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7900-0.0200 (-1.10%)
At close: 4:00PM EDT

1.8100 +0.02 (1.12%)
After hours: 6:55PM EDT

Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.22
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.9000
52 Week Low 31.4600
50-Day Moving Average 32.4012
200-Day Moving Average 32.4190

Share Statistics

Avg Vol (3 month) 31.16M
Avg Vol (10 day) 39.09M
Shares Outstanding 5139.8M
Implied Shares Outstanding 6N/A
Float 95.66M
% Held by Insiders 131.01%
% Held by Institutions 129.85%
Shares Short (Mar 30, 2021) 42.09M
Short Ratio (Mar 30, 2021) 41.07
Short % of Float (Mar 30, 2021) 42.04%
Short % of Shares Outstanding (Mar 30, 2021) 41.49%
Shares Short (prior month Feb 25, 2021) 41.76M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:11
Last Split Date 3Jun 30, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-220.02%

Management Effectiveness

Return on Assets (ttm)-18.08%
Return on Equity (ttm)-48.18%

Income Statement

Revenue (ttm)15.14M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)258.80%
Gross Profit (ttm)5.63M
EBITDA -31.35M
Net Income Avi to Common (ttm)-48.29M
Diluted EPS (ttm)-0.4370
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)66.37M
Total Cash Per Share (mrq)0.47
Total Debt (mrq)3.2M
Total Debt/Equity (mrq)3.09
Current Ratio (mrq)9.28
Book Value Per Share (mrq)0.66

Cash Flow Statement

Operating Cash Flow (ttm)-25.89M
Levered Free Cash Flow (ttm)-25.87M